Recent Quotes
My Watchlist
Indicators
Silicon Valley 150
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CRISPR Therapeutics AG - Common Shares (NQ:CRSP)

55.21 +0.63 (+1.15%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,111,809
Open 54.18
Bid (Size) 55.35 (100)
Ask (Size) 57.31 (100)
Prev. Close 54.58
Today's Range 52.82 - 56.15
52wk Range 30.04 - 78.48
Shares Outstanding 78,935,098
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
CRISPR Therapeutics' Investigational Gene Therapy Shows Promising Lipid-Lowering Effects In Early Trial
CRISPR Therapeutics' CTX310 trial shows strong, sustained lipid reductions and favorable safety, boosting confidence in its gene editing platform. 
Via Benzinga
Why Gene-Editing Giants Crispr And Intellia Just Surged
The companies are working on one-and-done treatments for diseases tied to genetic problems. 
Via Investor's Business Daily
Topics Death

Performance

YTD
+33.3%
+33.3%
1 Month
-19.2%
-19.2%
3 Month
-0.4%
-0.4%
6 Month
+46.9%
+46.9%
1 Year
+0.6%
+0.6%

More News

Read More
Retail Bulls Call CRISPR ‘Criminally Undervalued’ After Gene-Editing Breakthrough Cuts Cholesterol By 70%
Via Stocktwits
Intellia Therapeutics Crashes After A Patient In Its Pivotal Study Dies
Via Investor's Business Daily
Topics Death
AI Unlocks Gene-Editing Revolution: $2 Million Grant Propels Disease Cures
Via TokenRing AI
Topics Artificial Intelligence Climate Change Intellectual Property
Cathie Wood Goes All-In On Peter Thiel's Crypto Play Bullish With Back-To-Back Million-Dollar Buys
Via Benzinga
AI Unleashes a New Era in Cell and Gene Therapy: A Quarter Century Update Reveals Transformative Potential
Via TokenRing AI
Topics Artificial Intelligence
Prediction: 2 Stocks That Will Be Worth More Than SoundHound AI 2 Years From Now
Via The Motley Fool
Topics Artificial Intelligence
How Is The Market Feeling About CRISPR Therapeutics?
Via Benzinga
Intellia Freezes Key Trial After Serious Liver Event, Stock Tumbles
Via Benzinga
2 Soaring Cathie Wood Stocks to Buy and Hold
Via The Motley Fool
New to Growth Stocks? Here's 1 Every Investor Should Have on Their Radar.
Via The Motley Fool
3 Monster Stocks to Hold for the Next 10 Years
Via The Motley Fool
4 Healthcare Stocks to Buy Now
Via The Motley Fool
Topics Artificial Intelligence
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Healthcare Stocks Are Rising: Here Are 2 With Even More Upside Ahead
Via The Motley Fool
Topics Government World Trade
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Navigating the Future: Unlocking Investment Opportunities in High-Growth Sectors
Via MarketMinute
Topics Artificial Intelligence Climate Change Economy
3 Growth Stocks That Could Be 10-Baggers in 10 Years
Via The Motley Fool
Got $200? 2 Healthcare Stocks to Buy and Hold Forever
Via The Motley Fool
Could This Beaten-Down Stock Help You Become a Millionaire?
Via The Motley Fool
Topics ETFs
The Pharmaceutical Revolution: AI, Gene Therapies, and Obesity Drugs Reshape a Trillion-Dollar Market
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
My Top Biotech Stock Picks And Portfolio Strategy For The Next 3-10 Years
Via Benzinga
Global Cell Therapy Market Size Expected to Reach $44 Billion as Demand for Regenerative Medicine Rises
Via FinancialNewsMedia
Topics Artificial Intelligence
Cathie Wood Goes Bargain Hunting: She Just Bought 2 Stocks That Wall Street Thinks Will Climb 50% and 190%
Via The Motley Fool

Frequently Asked Questions

Is CRISPR Therapeutics AG - Common Shares publicly traded?
Yes, CRISPR Therapeutics AG - Common Shares is publicly traded.
What exchange does CRISPR Therapeutics AG - Common Shares trade on?
CRISPR Therapeutics AG - Common Shares trades on the Nasdaq Stock Market
What is the ticker symbol for CRISPR Therapeutics AG - Common Shares?
The ticker symbol for CRISPR Therapeutics AG - Common Shares is CRSP on the Nasdaq Stock Market
What is the current price of CRISPR Therapeutics AG - Common Shares?
The current price of CRISPR Therapeutics AG - Common Shares is 55.21
When was CRISPR Therapeutics AG - Common Shares last traded?
The last trade of CRISPR Therapeutics AG - Common Shares was at 11/11/25 04:00 PM ET
What is the market capitalization of CRISPR Therapeutics AG - Common Shares?
The market capitalization of CRISPR Therapeutics AG - Common Shares is 4.36B
How many shares of CRISPR Therapeutics AG - Common Shares are outstanding?
CRISPR Therapeutics AG - Common Shares has 4B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.